Form 4: DENTSPLY SIRONA Exec Boosts Equity Holdings
Insider Transaction Report
Robert Anthony Johnson, SVP, Chief Supply Chain Officer at DENTSPLY SIRONA Inc., increased his beneficial ownership through dividend reinvestment in common stock and phantom stock.
Summary
- Robert Anthony Johnson, SVP, Chief Supply Chain Officer of DENTSPLY SIRONA Inc. (XRAY), reported changes in beneficial ownership.
- Acquired 972.381 shares of Common Stock on October 10, 2025, through dividend reinvestment on restricted stock units (RSUs).
- These RSUs were acquired at a price of $0 and are subject to the same vesting terms as the underlying awards.
- Acquired 40.5116 shares of Phantom Stock (Supplemental Executive Retirement Plan SERP) on October 10, 2025, as a result of accrued dividends.
- Each share of phantom stock is the economic equivalent of one share of common stock and becomes payable upon termination of employment.
- Following these transactions, Johnson beneficially owns 124,187.521 shares of Common Stock and 3,072.9326 shares of Phantom Stock.
Sentiment
Score: 6
Explanation: The filing indicates a routine increase in insider ownership through dividend reinvestment, which is generally a neutral to slightly positive signal as it aligns executive interests with shareholders over the long term, without implying a strong new investment decision.
Positives
- Increased beneficial ownership by a senior executive, indicating continued alignment with shareholder interests.
- Dividend reinvestment demonstrates a long-term perspective on the company's equity.
Negatives
- No direct open market purchase, so it does not signal a new, active investment decision based on current market conditions.
Risks
- No specific risks are mentioned in this Form 4 filing.
Future Outlook
The acquired restricted stock units (RSUs) are subject to the same vesting terms as their underlying awards, and the phantom stock becomes payable in common stock upon the reporting person's termination of employment.
Management Comments
- Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards.
- The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
- Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.
- Comprised of phantom stock acquired as a result of accrued dividends.
Industry Context
This routine insider transaction reflects standard executive compensation practices, where dividends on equity awards are reinvested, aligning executive incentives with long-term company performance. It does not indicate any specific industry-wide trends or competitive shifts.
Comparison to Industry Standards
- NA
Stakeholder Impact
- Shareholders: Minor positive impact due to increased insider alignment, but no significant change in company fundamentals or strategy.
- Employees: No direct impact.
- Customers/Suppliers/Creditors: No direct impact.
Next Steps
- Continued vesting of the acquired restricted stock units (RSUs) according to their original terms.
- Phantom stock will become payable in common stock upon Robert Anthony Johnson's termination of employment.
Key Dates
| Date | Description |
|---|---|
| 10/10/2025 | Date of earliest transaction for acquisition of common stock and phantom stock. |
| 10/15/2025 | Date the Form 4 was signed by the attorney-in-fact for Robert Anthony Johnson. |
Recommendation
holdThis Form 4 filing details routine dividend reinvestments by a senior executive, which is a standard part of executive compensation. It does not indicate any new strategic developments, significant financial performance changes, or discretionary investment decisions that would warrant a change in investment recommendation. The transaction is neutral to slightly positive, reinforcing long-term alignment but not providing a catalyst for a 'buy' or 'sell' rating.
Keywords
DENTSPLY SIRONA, XRAY, Insider Transaction, Form 4, Robert Anthony Johnson, SVP, Chief Supply Chain Officer, Common Stock, Phantom Stock, RSU, SERP, Dividend Reinvestment, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.